Codexis Inc.: A Leader in Enzyme and Protein Development Redwood City, California-based Codexis Inc. is a renowned developer, discoverer, and seller of enzymes and other proteins. With two operating segments, namely Performance Enzymes and Novel Biotherapeutics, the firm offers a range of biocatalyst products and services, including biocatalyst panels and kits. These kits enable the company's customers to perform chemistry screening and provide biocatalyst screening and protein engineering services. Codexis Inc.'s CodeEvolver protein engineering technology platform is another pioneering product for the company. The platform helps develop and deliver biocatalysts that perform chemical transformations, enhancing the efficiency and productivity of manufacturing processes. Additionally, the platform also assists in discovering novel biotherapeutic drug candidates for targeted human diseases, molecular biology, and in vitro diagnostic enzymes. Codexis has also entered into a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company presently sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis Inc. was incorporated in 2002 and has since established itself as a leader in the biocatalyst industry. The Wall Street Journal predicts a bright future for the company as it continues to make strides in enzyme and protein development.
Codexis's ticker is CDXS
The company's shares trade on the NASDAQ stock exchange
They are based in Redwood City, California
There are 51-200 employees working at Codexis
It is codexis.com
Codexis is in the Healthcare sector
Codexis is in the Biotechnology industry
The following five companies are Codexis's industry peers: